Biosyntia Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $4.78M
Latest Deal Amount
  • Investors
  • 7

Biosyntia General Information

Description

Developer of bio-catalysts intended to produce complex chemical compounds by fermentation. The company assists in the production of chemical compounds including flavors, fragrances, APIs, pigments, additives, intermediates, and vitamins by applying synthetic biology and metabolic engineering, enabling clients to establish greener and sustainable manufacturing processes for their production purposes in reduced production costs and environmental impact.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Multi-line Chemicals
Primary Office
  • Fruebjergvej 3, boks 54
  • 2100 Copenhagen
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosyntia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 23-May-2018 $4.78M 00.000 Completed Generating Revenue
4. Seed Round 21-May-2015 00.000 00.000 Completed Generating Revenue
3. Grant 01-Dec-2013 Completed Startup
2. Grant 01-Jun-2013 $85K Completed Startup
1. Grant 01-Nov-2012 $145K Completed Startup
To view Biosyntia’s complete valuation and funding history, request access »

Biosyntia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-catalysts intended to produce complex chemical compounds by fermentation. The company assists in the pr
Biotechnology
Copenhagen, Denmark
25 As of 2021
00.000
00000000000 00.000

00000 00

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
000000000000 000000000
Cambridge, MA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000 0000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
000000000 000000000
Boulder, CO
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosyntia Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Manus Bio Venture Capital-Backed Cambridge, MA 00 000.00 00000000000 000.00
000 00000000000000 Venture Capital-Backed Boulder, CO 00 000.00 0000000000 0 000.00
00000 Venture Capital-Backed Berkeley, CA 00 000.00 000000000 - 000.00
000000000 00000000 Venture Capital-Backed La Jolla, CA 000 00000 00000000000 00000
0000000 Venture Capital-Backed Menlo Park, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 5 competitors. Get the full list »

Biosyntia Patents

Biosyntia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3683227-A1 Cell factories for improved production of compounds and proteins dependent on iron sulfur clusters Withdrawn 16-Jan-2019 0000000000 0
CA-3069650-A1 Cell factory having improved iron-sulfur cluster delivery Pending 14-Jul-2017 0000000000
AU-2018300754-A1 Cell factory having improved iron-sulfur cluster delivery Pending 14-Jul-2017 0000000000
JP-2020527359-A Cell plant with improved transport of iron-sulfur clusters Pending 14-Jul-2017 000000000
EP-3652198-A1 Cell factory having improved iron-sulfur cluster delivery Pending 14-Jul-2017 C07K14/245

Biosyntia Executive Team (4)

Name Title Board Seat Contact Info
Martin Plambech Chief Executive Officer
Hans Genee Ph.D Co-Founder & Chief Science Officer
Morten Sommer Ph.D Co-Founder & Board Member
Andreas Laustsen Ph.D Co-Founder & Business Developer
To view Biosyntia’s complete executive team members history, request access »

Biosyntia Board Members (6)

Name Representing Role Since
Henrik Dalboge Biosyntia Working Chairman 000 0000
Joško Bobanović Ph.D Sofinnova Partners Board Member 000 0000
Morten Sommer Ph.D Self Co-Founder & Board Member 000 0000
Søren Carlsen Novo Holdings Board Member 000 0000
Søren Moller Ph.D Novo Holdings Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Biosyntia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosyntia Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sofinnova Partners Venture Capital Minority 000 0000 000000 0
European Union Seventh Framework Programme Government 000 0000 000000 0
Novo Holdings Venture Capital Minority 000 0000 000000 0
Intel Global Challenge University 000 0000 000000 0
Technical University of Denmark (Endowment) Limited Partner 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »